Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-02 to 2025-06-03
Current total value of award: $1072.26
Description: 4568430229!QUILLIVANT XR ORAL SUSP 120ML 5MG/ML